AnalystsSteven MahSteven Mah's Stock Forecasts
AnalystsSteven Mah
Analyst Ranking
Bottom 1%
#3565 out of 3582 analysts
Average Return
-36.02%
Win Rate
8%1 out of 13
Risk vs Reward
Poor
Good
Steven Mah's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ortho Clinical Diagnostics Holdings plcOCDX | +4.68% | $17.11 | $17.91 | 2021-02-21 - 2022-01-24 | Strong Buy |
Steven Mah's Stock Coverage
| Name / Ticker | # of Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Talis Biomedical CorpTLIS | 2 | Hold | $9.00 | +204.05% | Downgrades | 5 months ago |
Heska CorpHSKA | 2 | Strong Buy | $305.00 | +98.90% | Maintains | 6 months ago |
Natera IncNTRA | 2 | Strong Buy | $155.00 | +140.68% | Maintains | 7 months ago |
Akoya Biosciences IncAKYA | 1 | Strong Buy | $28.00 | +141.38% | Initiates Coverage On | 8 months ago |
Luminex CorpLMNX | 1 | Hold | $37.00 | +0.03% | Downgrades | 9 months ago |
Twist Bioscience CorpTWST | 1 | Strong Buy | $150.00 | +168.48% | Initiates Coverage On | 9 months ago |
Codexis IncCDXS | 1 | Strong Buy | $32.00 | +55.79% | Initiates Coverage On | 9 months ago |
Fulgent Genetics IncFLGT | 1 | Strong Buy | $140.00 | +130.57% | Maintains | a year ago |
Ortho Clinical Diagnostics Holdings plcOCDX | 1 | Strong Buy | $27.00 | +50.75% | Initiates Coverage On | a year ago |
Pacific Biosciences Of California IncPACB | 1 | Strong Buy | $52.00 | +387.35% | Upgrades | a year ago |
Oxford Immunotec Global PLCOXFD | 1 | Hold | $22.00 | N/A | Downgrades | a year ago |
Oncocyte CorpOCX | 1 | Strong Buy | $4.00 | N/A | Upgrades | a year ago |
Illumina IncILMN | 1 | Hold | $340.00 | N/A | Downgrades | a year ago |
Quidel CorpQDEL | 1 | Strong Buy | $250.00 | N/A | Maintains | 2 years ago |
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.